CRVS logo

Corvus Pharmaceuticals (CRVS) Earnings Per Share

Annual EPS

-$0.56
+$0.33+37.08%

December 31, 2023

Summary

Performance

1-Year Change

+37.08%

3-Year Change

-180%

5-Year Change

+67.25%

15-Year Change

+79.41%

CRVS EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.45%
CRVS annual earnings per share is higher than 70.45% of companies in Healthcare sector

Analysts Estimate

-$0.92
CRVS annual earnings per share is currently -39.26% lower than the consensus analysts' forecast

High & Low

All-time High

-$0.20

3-Year Low

-$1.03

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CRVS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 19, 2025
CRVS next annual earnings announcement is scheduled for Mar 19, 2025

OtherCRVSprofitabilitymetrics:

Annual Revenue

-
CRVS annual revenue value is unknown

Annual Gross Profit

-
CRVS annual gross profit value is unknown

Annual Operating Profit

-$23.41 M
CRVS annual operating income is -$23.41 million

Annual Net Income

-$27.03 M
CRVS annual net profit is -$27.03 million

Quarterly EPS

-$0.60
-$0.53-757.14%

September 30, 2024

Summary

Performance

3-Month Change

-757.14%

1-Year Change

-400%

3-Year Change

-185.71%

5-Year Change

-185.71%

CRVS Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.62%
CRVS quarterly earnings per share is higher than 29.62% of companies in Healthcare sector

Analysts Estimate

-$0.12
CRVS quarterly earnings per share is currently +400.00% higher than the consensus analysts' forecast

High & Low

All-time High

$0.92
CRVS quarterly earnings per share is currently -165.22% below its historical high of $0.92

3-Year Low

-$0.60
CRVS quarterly earnings per share is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CRVS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
CRVS next earnings announcement is scheduled for Mar 19, 2025

OtherCRVSprofitabilitymetrics:

Quarterly Revenue

-
CRVS quarterly revenue value is unknown

Quarterly Gross Profit

-
CRVS quarterly gross profit value is unknown

Quarterly Operating Profit

-$7.25 M
CRVS quarterly operating income is -$7.25 million

Quarterly Net Income

-$40.22 M
CRVS quarterly net profit is -$40.22 million

TTM EPS

-$0.92
-$0.48-109.09%

September 30, 2024

Summary

Performance

3-Month Change

-109.09%

1-Year Change

-43.75%

3-Year Change

-3.37%

5-Year Change

-3.37%

CRVS TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.83%
CRVS TTM earnings per share is higher than 59.83% of companies in Healthcare sector

Analysts Estimate

-$0.91
CRVS TTM earnings per share is currently +1.10% higher than the consensus analysts' forecast

High & Low

All-time High

$0.06
CRVS TTM earnings per share is currently -1633.33% below its historical high of $0.06

3-Year Low

-$1.06

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CRVS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
CRVS next earnings announcement is scheduled for Mar 19, 2025

OtherCRVSprofitabilitymetrics:

Annual Revenue

-
CRVS annual revenue value is unknown

Annual Gross Profit

-
CRVS annual gross profit value is unknown

Annual Operating Profit

-$23.41 M
CRVS annual operating income is -$23.41 million

Annual Net Income

-$27.03 M
CRVS annual net profit is -$27.03 million

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

Annual EPS

-$0.56
CRVS annual earnings per share is -$0.56

Annual Net Income

-$27.03 M
CRVS annual net profit is -$27.03 million

Shares Outstanding

64.26 M
CRVS shares outstanding is 64.26 million

CRVS EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+37.1%-400.0%-43.8%
3 y3 years-180.0%-185.7%-3.4%
5 y5 years+67.3%-185.7%-3.4%

CRVS EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+45.6%-757.1%at low-109.1%+13.2%
5 y5-year-180.0%+64.8%-165.2%at low-1633.3%+43.6%
alltimeall time-180.0%+79.4%-165.2%+88.9%-1633.3%+88.9%

Corvus Pharmaceuticals EPS History

DateAnnualQuarterlyTTM
Sep 2024
-
-$0.60(+757.1%)
-$0.92(+109.1%)
Jun 2024
-
-$0.07(-41.7%)
-$0.44(-13.7%)
Mar 2024
-
-$0.12(-7.7%)
-$0.51(-8.9%)
Dec 2023
-$0.56(-37.1%)
-$0.13(+8.3%)
-$0.56(-12.5%)
Sep 2023
-
-$0.12(-14.3%)
-$0.64(-23.8%)
Jun 2023
-
-$0.14(-17.6%)
-$0.84(-4.5%)
Mar 2023
-
-$0.17(-19.0%)
-$0.88(-1.1%)
Dec 2022
-$0.89(-13.6%)
-$0.21(-34.4%)
-$0.89(+1.1%)
Sep 2022
-
-$0.32(+77.8%)
-$0.88(+10.0%)
Jun 2022
-
-$0.18(0.0%)
-$0.80(-11.1%)
Mar 2022
-
-$0.18(-10.0%)
-$0.90(-15.1%)
Dec 2021
-$1.03(+415.0%)
-$0.20(-16.7%)
-$1.06(-1866.7%)
Sep 2021
-
-$0.24(-14.3%)
$0.06(-300.0%)
Jun 2021
-
-$0.28(-17.6%)
-$0.03(-72.7%)
Mar 2021
-
-$0.34(-137.0%)
-$0.11(-47.6%)
Dec 2020
-$0.20(-87.4%)
$0.92(-378.8%)
-$0.21(-86.1%)
Sep 2020
-
-$0.33(-8.3%)
-$1.51(-2.6%)
Jun 2020
-
-$0.36(-18.2%)
-$1.55(-4.9%)
Mar 2020
-
-$0.44(+15.8%)
-$1.63(+2.5%)
DateAnnualQuarterlyTTM
Dec 2019
-$1.59(-7.0%)
-$0.38(+2.7%)
-$1.59(+1.3%)
Sep 2019
-
-$0.37(-15.9%)
-$1.57(+0.6%)
Jun 2019
-
-$0.44(+10.0%)
-$1.56(+2.6%)
Mar 2019
-
-$0.40(+11.1%)
-$1.52(-13.1%)
Dec 2018
-$1.71(-37.1%)
-$0.36(0.0%)
-$1.75(-11.2%)
Sep 2018
-
-$0.36(-10.0%)
-$1.97(-11.7%)
Jun 2018
-
-$0.40(-36.5%)
-$2.23(-12.9%)
Mar 2018
-
-$0.63(+8.6%)
-$2.56(-5.9%)
Dec 2017
-$2.72(+15.3%)
-$0.58(-6.5%)
-$2.72(+1.1%)
Sep 2017
-
-$0.62(-15.1%)
-$2.69(+4.3%)
Jun 2017
-
-$0.73(-7.6%)
-$2.58(+13.2%)
Mar 2017
-
-$0.79(+43.6%)
-$2.28(-66.9%)
Dec 2016
-$2.36(+53.7%)
-$0.55(+7.8%)
-$6.88(+3.8%)
Sep 2016
-
-$0.51(+18.6%)
-$6.63(+2.4%)
Jun 2016
-
-$0.43(-92.0%)
-$6.47(-22.2%)
Mar 2016
-
-$5.39(+1721.6%)
-$8.31(+164.8%)
Dec 2015
-$1.54
-$0.30(-16.5%)
-$3.14(+10.4%)
Sep 2015
-
-$0.35(-84.4%)
-$2.84(+14.2%)
Jun 2015
-
-$2.27(+957.5%)
-$2.49(+1057.5%)
Mar 2015
-
-$0.22
-$0.22

FAQ

  • What is Corvus Pharmaceuticals annual earnings per share?
  • What is the all time high annual EPS for Corvus Pharmaceuticals?
  • What is Corvus Pharmaceuticals annual EPS year-on-year change?
  • What is Corvus Pharmaceuticals quarterly earnings per share?
  • What is the all time high quarterly EPS for Corvus Pharmaceuticals?
  • What is Corvus Pharmaceuticals quarterly EPS year-on-year change?
  • What is Corvus Pharmaceuticals TTM earnings per share?
  • What is the all time high TTM EPS for Corvus Pharmaceuticals?
  • What is Corvus Pharmaceuticals TTM EPS year-on-year change?

What is Corvus Pharmaceuticals annual earnings per share?

The current annual EPS of CRVS is -$0.56

What is the all time high annual EPS for Corvus Pharmaceuticals?

Corvus Pharmaceuticals all-time high annual earnings per share is -$0.20

What is Corvus Pharmaceuticals annual EPS year-on-year change?

Over the past year, CRVS annual earnings per share has changed by +$0.33 (+37.08%)

What is Corvus Pharmaceuticals quarterly earnings per share?

The current quarterly EPS of CRVS is -$0.60

What is the all time high quarterly EPS for Corvus Pharmaceuticals?

Corvus Pharmaceuticals all-time high quarterly earnings per share is $0.92

What is Corvus Pharmaceuticals quarterly EPS year-on-year change?

Over the past year, CRVS quarterly earnings per share has changed by -$0.48 (-400.00%)

What is Corvus Pharmaceuticals TTM earnings per share?

The current TTM EPS of CRVS is -$0.92

What is the all time high TTM EPS for Corvus Pharmaceuticals?

Corvus Pharmaceuticals all-time high TTM earnings per share is $0.06

What is Corvus Pharmaceuticals TTM EPS year-on-year change?

Over the past year, CRVS TTM earnings per share has changed by -$0.28 (-43.75%)